Overview
The primary objective of this study is to determine, in unblinded samples, whether artificial intelligence can classify specific blood RNA from patients with long COVID together and separately from apparently healthy normals and other medical conditions which share signs and symptoms of long COVID.
Description
Participants will be screened and provide two blood samples 30 (+/- 5) days apart. Based on the participants survey results they will be placed into one of eleven groups that reflect the type of Long COVID the patient is experiencing. Samples will be shipped to the sponsor who will attempt to use AI processes to validate the type of Long COVID and assess its severity. The long term goal is to develop a reliable test to identify the presence of Long COVID and its severity.
Eligibility
Inclusion Criteria:
- Mentally capable of understanding and completing informed consent for the study.
- Precipitants with a lab verified diagnosis of SARS-CoV-2 or clinician note/record that an appropriate rapid test for SARS-CoV-2 was positive.
- To qualify for long COVID group participants will need to have new, persistent symptoms related to SARS-CoV-2 infection. iv. No one under the age of 18.
Exclusion Criteria:
- Subject is unable to provide informed consent.
- Primary Investigator or Sub-Investigator determines the participant's ongoing medical complaints that began after 1 November 2019 are not related to SARS-COV-2 but another disease process.